These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19762785)

  • 1. Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir.
    Guo W; Wong S; Pudney J; Jasuja R; Hua N; Jiang L; Miller A; Hruz PW; Hamilton JA; Bhasin S
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2028-32. PubMed ID: 19762785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoside reverse transcriptase inhibitors prevent HIV protease inhibitor-induced atherosclerosis by ubiquitination and degradation of protein kinase C.
    Bradshaw EL; Li XA; Guerin T; Everson WV; Wilson ME; Bruce-Keller AJ; Greenberg RN; Guo L; Ross SA; Smart EJ
    Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1271-8. PubMed ID: 16822947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution.
    Hadigan C; Rabe J; Meininger G; Aliabadi N; Breu J; Grinspoon S
    Am J Clin Nutr; 2003 Feb; 77(2):490-4. PubMed ID: 12540412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the hypolipidemic effect of fish oil by inhibition of adipose tissue lipolysis with acipimox, a nicotinic acid analog.
    Seböková E; Klimes I; Hermann M; Minchenko A; Mitková A; Hromadová M
    Ann N Y Acad Sci; 1993 Jun; 683():183-91. PubMed ID: 8102515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice.
    Tu P; Bhasin S; Hruz PW; Herbst KL; Castellani LW; Hua N; Hamilton JA; Guo W
    Diabetes; 2009 Aug; 58(8):1739-48. PubMed ID: 19509018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor-alpha mediates gender differences in atherosclerosis induced by HIV protease inhibitors.
    Allred KF; Smart EJ; Wilson ME
    J Biol Chem; 2006 Jan; 281(3):1419-25. PubMed ID: 16299001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue deficiency results in severe hyperlipidemia and atherosclerosis in the low-density lipoprotein receptor knockout mice.
    Wang M; Gao M; Liao J; Qi Y; Du X; Wang Y; Li L; Liu G; Yang H
    Biochim Biophys Acta; 2016 May; 1861(5):410-8. PubMed ID: 26921684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in
    Samsoondar JP; Burke AC; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Pinkosky SL; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):647-656. PubMed ID: 28153881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma adiponectin is modestly decreased during 24-hour insulin infusion but not after inhibition of lipolysis by Acipimox.
    Dullaart RP; Riemens SC; Meinardi JR; Wolffenbuttel BH; Sluiter WJ
    Scand J Clin Lab Invest; 2005; 65(6):523-31. PubMed ID: 16179286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissue.
    den Boer MA; Berbée JF; Reiss P; van der Valk M; Voshol PJ; Kuipers F; Havekes LM; Rensen PC; Romijn JA
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):124-9. PubMed ID: 16269669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
    Nuotio-Antar AM; Hachey DL; Hasty AH
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1517-28. PubMed ID: 17878220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
    Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
    Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
    Segerlantz M; Bramnert M; Manhem P; Laurila E; Groop LC
    Eur J Endocrinol; 2003 Dec; 149(6):511-9. PubMed ID: 14640991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy.
    Murphy RL; Berzins B; Zala C; Fichtenbaum C; Dube MP; Guaraldi G; Torriani F; Belsey E; Mitchell C; Stein JH;
    AIDS; 2010 Mar; 24(6):885-90. PubMed ID: 19952712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice.
    Mencarelli A; Cipriani S; Renga B; Francisci D; Palladino G; Distrutti E; Baldelli F; Fiorucci S
    PLoS One; 2010 Oct; 5(10):e13238. PubMed ID: 20949026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acipimox on the lipolysis rate in subcutaneous adipose tissue of obese subjects.
    Flechtner-Mors M; Jenkinson CP; Alt A; Adler G; Ditschuneit HH
    Diabetes Metab Res Rev; 2001; 17(5):387-90. PubMed ID: 11747144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acipimox, a nicotinic acid derivative, on lipolysis in human adipose tissue and on cholesterol synthesis in human jejunal mucosa.
    Stirling C; McAleer M; Reckless JP; Campbell RR; Mundy D; Betteridge DJ; Foster K
    Clin Sci (Lond); 1985 Jan; 68(1):83-8. PubMed ID: 3964732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers.
    Pao VY; Lee GA; Taylor S; Aweeka FT; Schwarz JM; Mulligan K; Schambelan M; Grunfeld C
    AIDS; 2010 Jan; 24(2):265-70. PubMed ID: 19890203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Lipolysis With Acipimox Attenuates Postburn White Adipose Tissue Browning and Hepatic Fat Infiltration.
    Barayan D; Vinaik R; Auger C; Knuth CM; Abdullahi A; Jeschke MG
    Shock; 2020 Feb; 53(2):137-145. PubMed ID: 31425403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Lipolysis Ameliorates Diabetic Phenotype in a Mouse Model of Obstructive Sleep Apnea.
    Weiszenstein M; Shimoda LA; Koc M; Seda O; Polak J
    Am J Respir Cell Mol Biol; 2016 Aug; 55(2):299-307. PubMed ID: 26978122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.